Fwd: NIH Scientists Establish Proof-of-Concept for Host-Directed Tuberculosis Therapy

---------- Forwarded message ----------
From: National Institute of Allergy and Infectious Diseases (NIAID) <niaid@service.govdelivery.com>
Date: Fri, Jun 27, 2014 at 7:49 AM
Subject: NIH Scientists Establish Proof-of-Concept for Host-Directed Tuberculosis Therapy
To: iammejtm@gmail.com

Leading Research to Understand, Treat, and Prevent Infectious, Immunologic, and Allergic Diseases          Visit us on the Web NIH Scientists Establish Proof-of-Concept for Host-Directed Tuberculosis Therapy In a new study published in Nature, NIH scientists describe a new type of tuberculosis (TB) treatment that involves manipulating the body's response to TB bacteria rather than targeting the bacteria themselves, a concept called host-directed therapy. This strategy could be of particular benefit to people infected with drug-resistant TB strains who have limited options for effective antibiotics.  For more information, visit: http://www.niaid.nih.gov/news/newsreleases/2014/Pages/HostDirectedTBtherapy.aspx.   Update your subscriptions, modify your password or e-mail address, or stop subscriptions at any time on your Subscriber Preferences Page. You will need to use your e-mail address to log in. If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. This service is provided to you at no charge by National Institute of Allergy and Infectious Diseases (NIAID). This email was sent to iammejtm@gmail.com using GovDelivery, on behalf of: National Institute of Allergy and Infectious Diseases · 6610 Rockledge Drive · Bethesda, MD 20892 · 866-284-4107

--
Jeremy Tobias Matthews